Skip to main content
All lobbying clients

VIATRIS (MYLAN, INC)

Lobbying client · Pennsylvania · filed 2025 to 2026

Generics and specialty pharmaceutical company

$360,000 Reported spend
7 Filings counted
1 Firms hired
5 Bills named

Spend is reported income plus in-house expenses across 7 filings. 2 further filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the client's LDA id (66077), not by name.

 Firms hired 1
 Bills named in these filings 5
  • HR 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
    7 filings
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
    7 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    5 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    5 filings
  • S 527
    Prescription Pricing for the People Act of 2025
    5 filings
 Reported by year 2 years
  • 2026 $120,000 2 filings
  • 2025 $240,000 5 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem